170 related articles for article (PubMed ID: 29469198)
1. Dose-escalation is needed for gross disease in high-risk neuroblastoma.
Casey DL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Pediatr Blood Cancer; 2018 Jul; 65(7):e27009. PubMed ID: 29469198
[TBL] [Abstract][Full Text] [Related]
2. Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement.
Ferris MJ; Danish H; Switchenko JM; Deng C; George BA; Goldsmith KC; Wasilewski KJ; Cash WT; Khan MK; Eaton BR; Esiashvili N
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):806-812. PubMed ID: 28244417
[TBL] [Abstract][Full Text] [Related]
3. Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma.
Casey DL; Kushner BH; Cheung NK; Modak S; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):393-400. PubMed ID: 27473818
[TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.
Kushner BH; Wolden S; LaQuaglia MP; Kramer K; Verbel D; Heller G; Cheung NK
J Clin Oncol; 2001 Jun; 19(11):2821-8. PubMed ID: 11387353
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of proton therapy in children with high-risk and locally recurrent neuroblastoma.
Bagley AF; Grosshans DR; Philip NV; Foster J; McAleer MF; McGovern SL; Lassen-Ramshad Y; Mahajan A; Paulino AC
Pediatr Blood Cancer; 2019 Aug; 66(8):e27786. PubMed ID: 31050179
[TBL] [Abstract][Full Text] [Related]
6. Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial.
Casey DL; Kushner BH; Cheung NV; Modak S; Basu EM; Roberts SS; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):409-414. PubMed ID: 30763661
[TBL] [Abstract][Full Text] [Related]
7. Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?
Casey DL; Pitter KL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1204-1209. PubMed ID: 29439882
[TBL] [Abstract][Full Text] [Related]
8. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
Paulino AC; Mayr NA; Simon JH; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
[TBL] [Abstract][Full Text] [Related]
9. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
Liao Z; Strom EA; Buzdar AU; Singletary SE; Hunt K; Allen PK; McNeese MD
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1191-200. PubMed ID: 10889372
[TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.
Kushner BH; Cheung NK; Barker CA; Kramer K; Modak S; Yataghene K; Wolden SL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1181-6. PubMed ID: 19427746
[TBL] [Abstract][Full Text] [Related]
11. Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma.
Zschaeck S; Wust P; Graf R; Misch M; Onken J; Ghadjar P; Badakhshi H; Florange J; Budach V; Kaul D
Radiat Oncol; 2018 Dec; 13(1):251. PubMed ID: 30567592
[TBL] [Abstract][Full Text] [Related]
12. Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma.
Pai Panandiker AS; Beltran C; Billups CA; McGregor LM; Furman WL; Davidoff AM
Pediatr Blood Cancer; 2013 May; 60(5):761-5. PubMed ID: 23024112
[TBL] [Abstract][Full Text] [Related]
13. Local Control and Clinical Outcome of High-risk Pediatric Neuroblastoma Patients After Receiving Multimodality Treatment and Helical Tomotherapy.
Chen GY; Cheng JC; Chen YH; Lu MY; Chang HH; Yang YL; Jou ST; Hsu WM; Kuo SH
Anticancer Res; 2019 Apr; 39(4):2207-2215. PubMed ID: 30952769
[TBL] [Abstract][Full Text] [Related]
14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience.
Robbins JR; Krasin MJ; Pai Panandiker AS; Watkins A; Wu J; Santana VM; Furman WL; Davidoff AM; McGregor LM
J Pediatr Surg; 2010 Apr; 45(4):678-86. PubMed ID: 20385270
[TBL] [Abstract][Full Text] [Related]
16. Excellent local control from radiation therapy for high-risk neuroblastoma.
Gatcombe HG; Marcus RB; Katzenstein HM; Tighiouart M; Esiashvili N
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1549-54. PubMed ID: 19211198
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative radiation therapy for high-risk pediatric neuroblastoma.
Haas-Kogan DA; Fisch BM; Wara WM; Swift PS; Farmer DL; Harrison MR; Albanese C; Weinberg V; Matthay KK
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):985-92. PubMed ID: 10863069
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
[TBL] [Abstract][Full Text] [Related]
19. Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 Study.
Liu KX; Naranjo A; Zhang FF; DuBois SG; Braunstein SE; Voss SD; Khanna G; London WB; Doski JJ; Geiger JD; Kreissman SG; Grupp SA; Diller LR; Park JR; Haas-Kogan DA
J Clin Oncol; 2020 Aug; 38(24):2741-2752. PubMed ID: 32530765
[TBL] [Abstract][Full Text] [Related]
20. Implications of Image-Defined Risk Factors and Primary-Site Response on Local Control and Radiation Treatment Delivery in the Management of High-Risk Neuroblastoma: Is There a Role for De-escalation of Adjuvant Primary-Site Radiation Therapy?
Lucas JT; McCarville MB; Cooper DA; Doubrovin M; Wakefield D; Santiago T; Li Y; Li X; Krasin M; Santana V; Furman W; Davidoff AM
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):869-877. PubMed ID: 30496881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
